Trump warns China of possible consequences for pandemic

Linda J. Dodson

WASHINGTON (Reuters) — U.S. President Donald Trump said on Saturday that China should face consequences if it was “knowingly responsible” for the coronavirus pandemic.

“If it was a mistake, a mistake is a mistake. But if they were knowingly responsible, yeah, I mean, then sure there should be consequences,” Trump told reporters at a daily briefing. He did not elaborate on what actions the United States might take.

Trump and senior aides have sharply criticized China for a lack of transparency after the coronavirus broke out in its Wuhan province. This week he suspended aid to the World Health Organization accusing it of being “China-centric.”

Washington and Beijing, the world’s two biggest economies, have publicly sparred over the virus repeatedly. Trump initially praised China’s response to the outbreak, but he and other senior officials have also referred to it as the “Chinese virus” and in recent days have ratcheted up their rhetoric.

Trump said the U.S.-China relationship was good “until they did this,” citing a recent first-phase agricultural deal aimed at quelling a trade war between the two countries.

He said the question now was whether what happened with the coronavirus was “a mistake that got out of control, or was it done deliberately?”

“There’s a big difference between those two,” he said.

Trump also raised questions about a Wuhan virology laboratory that Fox News this week reported had likely developed the coronavirus as part of China’s effort to demonstrate its capacity to identify and combat viruses. Trump has said his government is seeking to determine whether the virus emanated from a Chinese lab.

Trump also again cast doubt on China’s death toll, which was revised up on Friday. China said 1,300 people who died of the coronavirus in the central city of Wuhan – half the total – were not counted, but dismissed allegations of a cover-up.

Source Article

Next Post

Blood plasma treatment for coronavirus set for Japan trial

TOKYO — Japan will begin a clinical trial of a blood plasma treatment for coronavirus patients as early as this month, joining the U.S., Canada and China in experimenting with the century-old treatment. The treatment involves infusing into patients blood plasma harvested from those who have recovered from COVID-19, the disease […]

You May Like